Anderson W M, Delinck D L, Benninger L, Wood J M, Smiley S T, Chen L B
Indiana University School of Medicine, Northwest Center for Medical Education, Gary 46408.
Biochem Pharmacol. 1993 Feb 9;45(3):691-6. doi: 10.1016/0006-2952(93)90144-l.
Five lipophilic-cationic thiacarbocyanine compounds differing in the side chains (methyl-S13, ethyl-S23, propyl-S33, butyl-S43, and pentyl-S53) and a related thiadicarbocyanine compound with ethyl side chains (S25) exhibited a selective cytotoxic effect on human colon carcinoma cells compared to green monkey kidney epithelial cells. The inhibitory concentration for 50% inhibition of growth (IC50) for the carcinoma cells ranged from 13 nM for S13 and S23 to 160 nM for S25. The carcinoma cells were 4- to 100-fold more sensitive than the normal cells. Two of the five compounds, S13 and S23, selectively inhibited NADH oxidase activity with bovine heart submitochondrial particles (SMP). There was no discernable inhibitory effect by the other three thiacarbocyanine compounds on electron transport chain activity. The primary site of inhibition within the respiratory chain for S13 and S23 appeared to be the NADH to coenzyme Q portion of the mitochondrial electron transport chain. Artificial electron acceptors for this segment of respiratory chain were used to localize the inhibitory site. Using SMP, both S13 and S23 inhibited reduction of menadione, duroquinone, and coenzyme Q. Using purified complex I (NADH-ubiquinone reductase) (EC 1.6.99.3), S13 slightly inhibited reduction of juglone, duroquinone, and coenzyme Q, whereas S23 had no effect on any of the substrates. When rotenone-saturated SMP were used, the inhibitory effects of S13, but not S23, on the reduction of menadione were abolished, as was the inhibitory effect of S13 on coenzyme Q reduction when rotenone-insensitive complex I was used as the source of the enzyme. These results suggest that (1) S13 and S23 inhibition of NADH-ubiquinone reductase activity is enhanced by the membrane environment of the enzyme, and (2) the inhibition appears to be in part akin to the inhibiting mode of rotenone.
五种侧链不同的亲脂性阳离子硫代碳菁化合物(甲基-S13、乙基-S23、丙基-S33、丁基-S43和戊基-S53)以及一种具有乙基侧链的相关硫二碳菁化合物(S25),与绿猴肾上皮细胞相比,对人结肠癌细胞表现出选择性细胞毒性作用。癌细胞生长抑制50%的抑制浓度(IC50)范围为S13和S23的13 nM至S25的160 nM。癌细胞比正常细胞敏感4至100倍。五种化合物中的两种,S13和S23,用牛心亚线粒体颗粒(SMP)选择性抑制NADH氧化酶活性。其他三种硫代碳菁化合物对电子传递链活性没有明显的抑制作用。S13和S23在呼吸链中的主要抑制位点似乎是线粒体电子传递链中从NADH到辅酶Q的部分。使用该呼吸链片段的人工电子受体来定位抑制位点。使用SMP时,S13和S23均抑制甲萘醌、杜醌和辅酶Q的还原。使用纯化的复合物I(NADH-泛醌还原酶)(EC 1.6.99.3)时,S13轻微抑制胡桃醌、杜醌和辅酶Q的还原,而S23对任何底物均无影响。当使用鱼藤酮饱和的SMP时,S13对甲萘醌还原的抑制作用被消除,当使用对鱼藤酮不敏感的复合物I作为酶源时,S13对辅酶Q还原的抑制作用也被消除。这些结果表明:(1)S13和S23对NADH-泛醌还原酶活性的抑制作用因酶的膜环境而增强;(2)这种抑制作用似乎部分类似于鱼藤酮的抑制模式。